However, as the early warning signs already apparent during clinical trials begin to translate into serious adverse reactions on a wider scale, officials now face a new public relations challenge — that of “managing expectations” to ensure population willingness to take the vaccine.
As more people hear about adverse events, and more adverse events occur — ranging from life-threatening anaphylaxis and emergency room visits to brain inflammation and death — “selling” the experimental injections may become an increasingly uphill battle....<<<Read The Full Article Here>>>...
